Model‐informed drug development of autologous CAR‐T cell therapy: Strategies to optimize CAR‐T cell exposure leveraging cell kinetic/dynamic modeling
Abstract Autologous Chimeric antigen receptor (CAR‐T) cell therapy has been highly successful in the treatment of aggressive hematological malignancies and is also being evaluated for the treatment of solid tumors as well as other therapeutic areas. A challenge, however, is that up to 60% of patient...
Saved in:
Main Authors: | Anna M. Mc Laughlin (Author), Peter A. Milligan (Author), Cassian Yee (Author), Martin Bergstrand (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Engineering CAR-T cells
by: Cheng Zhang, et al.
Published: (2017) -
Donor T cells for CAR T cell therapy
by: Tiffany C. Y. Tang, et al.
Published: (2022) -
Immunogenicity in CAR T cell immunotherapy
by: Emily Yu
Published: (2023) -
The EBMT/EHA CAR-T Cell Handbook
Published: (2022) -
The EBMT/EHA CAR-T Cell Handbook
Published: (2022)